National Peroxide
Market Cap
₹12.2b
Last Updated
2019/10/19 12:43 UTC
Data Sources
Company Financials
Executive Summary
National Peroxide Limited manufactures and sells peroxygens in India.
Snowflake
Fundamentals
Flawless balance sheet, good value and pays a dividend.
Share Price & News
How has National Peroxide's share price performed over time and what events caused price changes?
Latest Share Price and Events
Market Performance
7 Day Return
14.5%
500298
1.9%
IN Chemicals
3.2%
IN Market
1 Year Return
-53.8%
500298
17.2%
IN Chemicals
5.6%
IN Market
Return vs Industry: 500298 underperformed the Indian Chemicals industry which returned 17.2% over the past year.
Return vs Market: 500298 underperformed the Indian Market which returned 5.6% over the past year.
Shareholder returns
| 500298 | Industry | Market | |
|---|---|---|---|
| 7 Day | 14.5% | 1.9% | 3.2% |
| 30 Day | 11.2% | 8.6% | 6.0% |
| 90 Day | 10.4% | 11.6% | 2.0% |
| 1 Year | -52.2%-53.8% | 20.2%17.2% | 7.8%5.6% |
| 3 Year | 132.2%114.6% | 37.5%32.0% | 22.6%16.3% |
| 5 Year | 308.9%269.6% | 130.6%112.8% | 43.1%29.6% |
Price Volatility Vs. Market
How volatile is National Peroxide's share price compared to the market and industry in the last 5 years?
Simply Wall St News
1 year ago | Simply Wall St
What Do Expectations Tell Us About National Peroxide Limited's (BOM:500298) Margins In The Years Ahead?1 year ago | Simply Wall St
May Growth Opportunities – Quess And More1 year ago | Simply Wall St
May Growth Opportunities – Quess And MoreValuation
Is National Peroxide undervalued compared to its fair value and its price relative to the market?
19.1%
Undervalued compared to fair value
Share Price vs. Fair Value
Undervalued: 500298 (₹2125.15) is trading below our estimate of fair value (₹2627.46)
Significantly Undervalued: 500298 is trading below fair value, but not by a significant amount.
Price To Earnings Ratio
PE vs Industry: 500298 is good value based on its PE Ratio (9.8x) compared to the Chemicals industry average (10.8x).
PE vs Market: 500298 is good value based on its PE Ratio (9.8x) compared to the Indian market (13.3x).
Price to Earnings Growth Ratio
Low PEG Ratio: Insufficient data to calculate 500298's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: 500298 is good value based on its PB Ratio (1x) compared to the IN Chemicals industry average (1.1x).
Next Steps
Future Growth
How is National Peroxide forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
11.1%
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 500298's forecast earnings growth (11.1% per year) is above the savings rate (7.6%).
Earnings vs Market: 500298's earnings (11.1% per year) are forecast to grow slower than the Indian market (18.3% per year).
High Growth Earnings: 500298's earnings are forecast to grow, but not significantly.
Revenue vs Market: Insufficient data to determine if 500298's revenue is forecast to grow faster than the Indian market.
High Growth Revenue: Insufficient data to determine if 500298's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
High Future ROE: Insufficient data to determine if 500298's Return on Equity is forecast to be high in 3 years time
Next Steps
Past Performance
How has National Peroxide performed over the past 5 years?
47.0%
Historical annual earnings growth
Earnings and Revenue History
Past Earnings Growth Analysis
Earnings Trend: 500298's earnings have grown significantly by 47% per year over the past 5 years.
Accelerating Growth: 500298's earnings growth over the past year (13%) is below its 5-year average (47% per year).
Earnings vs Industry: 500298 earnings growth over the past year (13%) exceeded the Chemicals industry 9.9%.
Return on Equity
High ROE: 500298's Return on Equity (10.6%) is considered low.
Return on Assets
ROA vs Industry: 500298's Return on Assets is below or equal to the Chemicals industry average last year.
Return on Capital Employed
ROCE Improving: 500298's Return on Capital Employed has declined over the past 3 years.
Next Steps
Financial Health
How is National Peroxide's financial position?
Financial Position Analysis
Short Term Liabilities: 500298's short term assets (₹3.3B) exceeds its short term liabilities (₹585.4M)
Long Term Liabilities: 500298's short term assets (3.3B) exceeds its long term liabilities (1.1B)
Debt to Equity History and Analysis
Debt Level: 500298's debt to equity ratio (7.3%) is considered satisfactory
Reducing Debt: 500298's debt to equity ratio has reduced from 10.2% to 7.3% over the past 5 years.
Debt Coverage: 500298's debt is well covered by operating cash flow (171.9%).
Interest Coverage: 500298 earns more interest than it pays, so coverage of interest payments is not a concern.
Balance Sheet
Inventory Level: 500298 has a high level of physical assets or inventory.
Debt Coverage by Assets: 500298's debt is covered by short term assets (assets are 3.865600x debt).
Next Steps
Dividend
What is National Peroxide's current dividend yield, its reliability and sustainability?
3.06%
Current Dividend Yield
Dividend Yield vs Market
Current dividend yield vs market & industry
Stability and Growth of Payments
Notable Dividend: 500298's dividend (3.06%) is higher than the bottom 25% of dividend payers in the Indian market (0.59%).
High Dividend: 500298's dividend (3.06%) is in the top 25% of dividend payers in the Indian market (2.43%)
Stable Dividend: 500298's dividend payments have been volatile in the past 10 years.
Growing Dividend: 500298's dividend payments have increased over the past 10 years.
Current Payout to Shareholders
Dividend Coverage: With its reasonably low payout ratio (30%), 500298's dividend payments are well covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: Insufficient data to determine if a dividend will be paid in 3 years and that it will be covered by earnings.
Next Steps
Management
What is the CEO of National Peroxide's salary, the management and board of directors tenure and is there insider trading?
0.8yrs
Average management tenure
CEO
Suresh Khurana (65yo)
1.8yrs
Tenure
₹22,061,560
Compensation
Mr. Suresh Khurana serves as Chief Executive Officer and Director at National Peroxide Ltd. He serves as the Chief Executive Officer of PSF at The Bombay Dyeing and Manufacturing Company Limited.
CEO Compensation Analysis
Compensation vs. Market: Insufficient data to establish whether Suresh's total compensation is reasonable compared to companies of similar size in the Indian market.
Compensation vs Earnings: Insufficient data to compare Suresh's compensation with company performance.
Management Age and Tenure
0.8yrs
Average Tenure
Experienced Management: 500298's management team is not considered experienced ( 0.8 years average tenure), which suggests a new team.
Board Age and Tenure
5.1yrs
Average Tenure
64yo
Average Age
Experienced Board: 500298's board of directors are considered experienced (5.1 years average tenure).
Insider Trading
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
| Entity | Individual |
| Role | Chairman of the Board Non Independent Non-Executive Chairman |
| Shares | 2,400 |
| Max Price | ₹4,394.34 |
| Entity | Individual |
| Role | Chairman of the Board Non Independent Non-Executive Chairman |
| Shares | 550 |
| Max Price | ₹4,312.12 |
| Entity | Individual |
| Role | Chairman of the Board Non Independent Non-Executive Chairman |
| Shares | 500 |
| Max Price | ₹4,764.53 |
| Entity | Individual |
| Role | Chairman of the Board Non Independent Non-Executive Chairman |
| Shares | 300 |
| Max Price | ₹5,036.38 |
| Entity | Individual |
| Role | Chairman of the Board Non Independent Non-Executive Chairman |
| Shares | 850 |
| Max Price | ₹5,002.35 |
Ownership Breakdown
Management Team
Suresh Khurana (65yo)
CEO & Director
- Tenure: 1.8yrs
- Compensation: ₹22.06m
Vinayak Pujar
General Manager of Marketing
- Tenure: 1.8yrs
Y. Parkar
Vice President of Technical & Projects
- Tenure: 0yrs
Conrad Fernandes (52yo)
Chief Financial Officer
- Tenure: 0.8yrs
Hasit Dangi
Vice President of Operations & Quality Assurance
- Tenure: 1.8yrs
Chandukumar Parmar
Company Secretary & Compliance Officer
- Tenure: 0.7yrs
Ajay Bhardwaj
Chief Human Resource Officer
- Tenure: 0.8yrs
Rajeev Pradhan
Chief Information Officer
- Tenure: 0.8yrs
Board Members
Sethumadhava Ragothaman (73yo)
Independent Non-Executive Director
- Tenure: 6.2yrs
- Compensation: ₹1.40m
Ness Wadia (48yo)
Non Independent Non-Executive Chairman
- Tenure: 8.5yrs
- Compensation: ₹4.39m
Rajesh Batra (64yo)
Independent Non-Executive Director
- Tenure: 13.8yrs
- Compensation: ₹2.25m
Minnie Bodhanwala (56yo)
Non- Independent Non-Executive Director
- Tenure: 4yrs
- Compensation: ₹700.70k
Suresh Khurana (65yo)
CEO & Director
- Tenure: 1.8yrs
- Compensation: ₹22.06m
Viraf Mehta (64yo)
Additional Non-Executive & Independent Director
- Tenure: 0.3yrs
Company Information
National Peroxide Limited's company bio, employee growth, exchange listings and data sources
Key Information
- Name: National Peroxide Limited
- Ticker: 500298
- Exchange: BSE
- Founded: 1954
- Industry: Commodity Chemicals
- Sector: Materials
- Market Cap: ₹12.213b
- Shares outstanding: 5.75m
- Website: https://www.naperol.com
Number of Employees
Location
- National Peroxide Limited
- C-1, Wadia International Center
- Pandurang Budhkar Marg
- Mumbai
- Maharashtra
- 400025
- India
Listings
| Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
|---|---|---|---|---|---|---|
| 500298 | BSE (Mumbai Stock Exchange) | Yes | Equity Shares | IN | INR | Jan 2002 |
Biography
National Peroxide Limited manufactures and sells peroxygens in India. It offers hydrogen peroxide that is used in various industries for bleaching, chemical synthesis, environmental control/effluent treatm ...
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2019/10/19 12:43 |
| End of Day Share Price | 2019/10/18 00:00 |
| Earnings | 2019/06/30 |
| Annual Earnings | 2019/03/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.